ElendiLabs Logo
返回文章列表

需要法規協助?試試我們的平台

發佈您的法規問題或向全球認證藥劑顧問申請報價。與專注於您所在市場的專家配對。

其他

2025年12月19日

約5分鐘

歐盟 MDR 與 IVDR 改革:建立更高效框架的里程碑提案

歐盟 MDR 與 IVDR 改革:建立更高效框架的里程碑提案

歐盟委員會已正式發布修改醫療器材法規 (MDR) 與體外診斷醫療器材法規 (IVDR) 的提案。這份包含主法案及兩個附錄、超過 200 頁的改革方案,標誌著監管環境向更具預見性、更少官僚主義的戰略轉型。

戰略性的結構變動

該提案引入了多個旨在促進創新和簡化市場准入的高階概念:

  • 突破性器材 (Breakthrough Devices): 為創新產品設立的新類別,可能為解決未滿足醫療需求的器材提供快速通道。
  • 取消 5 年有效期限制: 證書可能不再受限於僵化的 5 年重新認證週期,這將顯著減輕製造商和公告機構的行政負擔。
  • 預定變更控制計劃 (PCCP): 公告機構與製造商現在可以就變更計劃達成一致,明確哪些變更可以在無需事先通知或批准的情況下實施。

營運效率與靈活性

該改革解決了自原始法規實施以來業界反映的多個痛點:

  • PRRC 的靈活性: 對於中小企業,合規負責人 (PRRC) 不再需要「永久且持續」在岗,只需「可獲得」即可。詳細的資質要求也得到了簡化。
  • 警戒時限: 對於不涉及立即公共衛生威脅或死亡的嚴重事故,報告窗口已從 15 天延長至 30 天。
  • PSUR 更新: 定期安全性更新報告 (PSUR) 的頻率正在調整;對於 IIa 類器材,現在僅在「必要時」要求更新。
  • 抽樣改進: 公告機構在技術文件評估抽樣方面將採用改進後的程序,旨在實現更一致的審查結果。

技術定義與整合

技術要求的措辭正在發生微妙但影響巨大的變化:

  • 臨床與生物學定義: 在生物學和臨床評估中增加了「相同或相似」的術語,這將影響製造商如何證明等同性和生物相容性。
  • CER/PMCF 整合: 上市後臨床追蹤 (PMCF) 報告將直接整合到臨床評估報告 (CER) 中,從而精簡技術文件的結構。
  • 數位化: 新的第 48b 條和第 52b 條專門針對監管流程的數位化。

重新分類與風險特徵

有趣的是,部分分類規則正在進行調整,以反映對風險更細緻的理解。這可能導致特定類別的風險等級降低,例如:

  1. 重複使用的手術器械。
  2. 主動植入式器材的附件。
  3. 某些類型的軟體。

結論

該提案代表了歐洲醫療器材政策的一次重大轉向。通過解決認證週期中的瓶頸並引入更靈活的合規機制,歐盟委員會旨在確保監管框架能夠支持——而非阻礙——患者獲得安全且創新的技術。製造商應開始研究這 200 多頁的提案,以評估其對產品組合的長期影響。

有任何問題?

我們會親自跟進回覆您。

100% 回覆率 • 7個工作天內回覆

您的電郵不會被公開。我們只會用它來通知您我們的回覆。

問與答 (3)

A
訪客

We are currently selling a diagnostic SaMD (Software as a Medical Device) under the MDR transition period. If we migrate our hosting from a local server to an AWS/Azure cloud environment does this count as a "significant change" that would void our legacy status and force immediate MDR certification?

ElendiLabs

This depends on whether the migration affects the software's performance or intended purpose. According to MDCG 2020-3, changes to the "operating environment" are generally not considered significant if they don't alter the algorithm or user interface. However, if the cloud migration involves a change in how the software processes data or affects its cybersecurity profile, a Notified Body may deem it significant. We recommend a formal Significant Change Assessment to document why this move does not invalidate your legacy status.

A
訪客

Our company has been waiting for EUDAMED to be "fully functional" before registering our devices. With the new reform has the mandatory registration for the Actor UDI and Device modules been pushed back further?

ElendiLabs

Actually, the 2024 reform (Regulation 2024/1860) accelerates the mandatory use of certain EUDAMED modules. Instead of waiting for the entire system to be ready, the EU will make individual modules mandatory as they become functional. Actor registration, UDI/Device registration, and Certificates/Notified Body modules are expected to become mandatory as early as Q4 2025 or early 2026. Manufacturers should not wait; you should begin the registration process now to avoid a "bottleneck" once the legal mandate takes effect.

A
訪客

We have MDD-compliant stock in our warehouse manufactured before our certificate expired. Since the EU abolished the "sell-off" period can we continue to sell this stock to our distributors indefinitely?

ElendiLabs

Not necessarily. According to Regulation (EU) 2023/607, there is a critical distinction between "Placed on the Market" and "Made Available." 1. The "Placed on the Market" Hurdle: To sell your stock, it must have been "placed on the market" before your MDD certificate expired (or before the end of your specific extension period). This means you must have already transferred ownership (or have a written agreement to transfer) to a distributor or the end-user. ◦ If the devices are still in your warehouse (the manufacturer's control) and your certificate expires without a valid MDR extension, you cannot legally sell them to a distributor. They are "trapped" stock. 2. The "Made Available" (Sell-off) Freedom: If the devices were legally placed on the market (e.g., already sold to and sitting in a distributor’s warehouse) before your certificate lapsed, then yes, they can be "made available" (resold) to hospitals or patients without any regulatory cut-off date. 3. The Practical Limit (Shelf Life): While the law has no end date, the device is limited by its physical/chemical expiry date. You cannot sell an MDD-compliant device past its shelf life, and you cannot relabel it or extend the shelf life under the MDD once your certificate is gone.

需要專業指導?

聯絡我們 contact@elendilabs.com / +852 4416 5550